Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05659420
Other study ID # InhaUH
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2023
Est. completion date December 31, 2025

Study information

Verified date February 2023
Source Inha University Hospital
Contact Kyung-Lim Joa, M.D.
Phone +82-10-9111-9432
Email drjoakl@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate the effect of high-intensity interval training and moderate intensity continuous training on cardiopulmonary functions in chronic heart failure.


Description:

enroll chronic heart failure patients into 3 randomized controlled group - high intensity interval training - moderate intensity continous training - control perform cardica rehab for 12 weeks, compare primary and secondary endpoints between baseline and 12 weeks results


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 31, 2025
Est. primary completion date July 31, 2025
Accepts healthy volunteers No
Gender All
Age group 30 Years to 70 Years
Eligibility Inclusion Criteria: - medically stable chronic heart failure - NYHA II-III - can perform cardiopulmonary exercise test - after 3months with proper medication - age 30 to 70 - ejection fraction< 40% Exclusion Criteria: - contraindication to cardiopulmonary exercise test - musculoskeletal problem who cannot perform cardiopulmonary exercise test - cognition deficit who cannot understand directions - severe medial illness

Study Design


Intervention

Behavioral:
Cardiac rehabilitation comprised aerobic exercise on a treadmill accompanied by an electrocardiogram monitoring device and a blood pressure monitor
aerobic exercise on a treadmill (T7M, Motus, Paju, South Korea) accompanied by an electrocardiogram monitoring device (Q-Tel Rehabilitation Management System, Mortara Inc., Milwaukee, WI, USA) and a blood pressure monitor

Locations

Country Name City State
Korea, Republic of Inha University hospital Incheon Kyunggi-do

Sponsors (1)

Lead Sponsor Collaborator
Inha University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maximal or peak oxygen consumption (VO2max or VO2peak, same meaning) (kg/ml/min) at the end of training, from baseline to 12 weeks compare baseline data with 12 weeks rehabilitation data
Secondary Anaerobic threshold (kg/ml/min) The anaerobic threshold is the highest exercise intensity that you can sustain for a prolonged period without lactate substantially building up in your blood. compare baseline data with 12 weeks rehabilitation data
Secondary 6minute walk test (meter) compare baseline data with 12 weeks rehabilitation data
Secondary maximal heart rate (bpm) compare baseline data with 12 weeks rehabilitation data
Secondary systolic blood pressure (mmHg) compare baseline data with 12 weeks rehabilitation data
Secondary diastolic blood pressure (mmHg) compare baseline data with 12 weeks rehabilitation data
Secondary resting heart rate (bpm) compare baseline data with 12 weeks rehabilitation data
Secondary diastolic blood presure (mmHg) compare baseline data with 12 weeks rehabilitation data
Secondary depression scale by Patient Health Questionnaire Patient Health Questionnaire (PHQ; range, 0-27; higher score = severe depression; cut-off score of 5 for minimal depression) compare baseline data with 12 weeks rehabilitation data
Secondary anxiety scale by Generalized Anxiety Disorder Scale Generalized Anxiety Disorder Scale (GAD; range, 0-21; higher score = severe anxiety; cut-off score of 5 for mild anxiety) compare baseline data with 12 weeks rehabilitation data
Secondary fatigue scale by fatigue severity scale fatigue severity scale (FSS; range, 9-63; higher score = severe fatigue; cut-off score of 4 for fatigue) compare baseline data with 12 weeks rehabilitation data
Secondary Quality of Life (QoL) questionnaire (MacNew) MacNew QoL questionnaire is a measurement tool for patients with cardiac disease that measures physical, emotional, and social functional levels to provide overall QoL. compare baseline data with 12 weeks rehabilitation data
See also
  Status Clinical Trial Phase
Completed NCT03597646 - The Effect of Kinesio Taping on Pulmonary Function and Functional Capacity in Patients With Chronic Heart Failure N/A
Terminated NCT04065997 - Apogee International
Withdrawn NCT03675113 - Effect of Upper Extremity Aerobic Exercise Training on Exercise Capacity Patients With Chronic Heart Failure N/A
Completed NCT02916160 - Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study Phase 4
Completed NCT03126656 - Effects of Testosterone on Myocardial Repolarization Phase 4
Completed NCT02268500 - VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT) Phase 4
Completed NCT02247245 - The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients. N/A
Completed NCT01919918 - Muscle Afferent Feedback Effects in Patients With Heart Failure Phase 1
Terminated NCT01906957 - Cognition and Exercise Training N/A
Not yet recruiting NCT01669395 - Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial N/A
Completed NCT00984529 - Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia N/A
Recruiting NCT00863421 - Sleep Disordered Breathing in Patients With Chronic Heart Failure N/A
Completed NCT02840565 - Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453 Phase 1
Completed NCT02441218 - Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study Phase 3
Completed NCT00149409 - Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure Phase 2/Phase 3
Terminated NCT05532046 - A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT) Phase 1
Recruiting NCT04984928 - Readmission Risk of Patients With Heart Failure.
Completed NCT02814097 - A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction Phase 2
Active, not recruiting NCT05560737 - ODYSSEE-vCHAT Mental Health Program for Heart Failure and Kidney Disease Patients
Recruiting NCT03286127 - Palliative Outcome Evaluation Muenster I